Pirfenidone

Red

Brand Name(s): Esbriet

Indication:Idiopathic pulmonary fibrosis- mild to moderate in adults

Rationale:1,2,8

Considered:May-13

Review Date:Jan-26

Comments:
MHRA advises liver function tests before starting treatment, monthly for the first 6 months and then every 3 months thereafter due to risk of serious liver injury. November 2020

For management of IPF see:http://www.nice.org.uk/nicemedia/live/14183/64124/64124.pdf
NICE clinical guideline 163 June 2013